الفهرس 
ACUTE MYOCARDIAL I NFARCTIONOnly 14 pages are availabe for public view
 |  | from | 140 |  |  |
| | | from | 140 | | |
Abstract
Background: tramadol has been in clinical use in Germany since the late 1970s and has proven effective in both experimental and clinical pain without causing serious cardiovascular or respiratory side effects. However, electrocardiogram ST segment elevation is found among people who take Tramadol, especially for people who are female, 60+ old, have been taking the drug for < 1 month, also take medication Aspirin, and have Arrhythmias. Aim of the Work: the aim of this study was to determine the prevalence of Tramadol users in STEMI patients. Patients and Methods: this cross-section study was designed and conducted in the Cardiovascular Diseases Unit at Ain Shams University hospitals on one thousand (1000) patients presenting to Ain Shams University hospital with STEMI at coronary care unit. Results: in the present study there was highly significant evidence relation between Tramadol users and STEMI depended on the amount and duration of the Tramadol dose. Recommendations: the present study confirms the relation between Tramadol users and STEMI. However, further studies are needed to assess the thrombogencity effect of Tramadol on the coronary and cardiovascular system.